Target intelligence / Profile preview

Ventilation regulation

Molecular classification
Other
01

Overview

Ventilation regulation is a complex physiological process that maintains stable levels of oxygen and carbon dioxide in the blood by adjusting the rate and depth of breathing [3][12]. This system is controlled by the medullary and pontine respiratory centers in the brainstem, which integrate signals from central chemoreceptors (sensing pH and CO2 in the cerebrospinal fluid) and peripheral chemoreceptors in the carotid and aortic bodies (sensing O2, CO2, and pH) [3][6]. The primary drive for ventilation in healthy individuals is the accumulation of carbon dioxide, though hypoxic drive becomes critical in certain disease states [12]. Pharmacological modulation of this system is used to treat respiratory depression, sleep apnea, and chronic obstructive pulmonary disease (COPD) [11]. While not a single molecular target, it involves various discrete targets such as TASK-1/3 potassium channels, P2X3 receptors, and adenosine receptors, which are the focus of therapeutic interventions to stimulate or stabilize breathing patterns [6][11].

Other names
Respiratory controlVentilatory controlControl of breathingRegulation of respiration
02

Mechanism of action

Modulation occurs via several mechanisms: inhibition of TASK-1 and TASK-3 potassium channels in carotid body glomus cells (e.g., doxapram), inhibition of carbonic anhydrase to induce metabolic acidosis and stimulate central chemoreceptors (e.g., acetazolamide), and antagonism of adenosine receptors to increase central respiratory drive (e.g., caffeine, theophylline).

03

Biological functions

Regulation of gas exchangeAcid-base homeostasisMaintenance of arterial blood gas levels (PaO2, PaCO2)Integration of chemosensory feedback
04

Disease associations

Sleep apnea (central and obstructive)Opioid-induced respiratory depression (OIRD)Chronic obstructive pulmonary disease (COPD)Respiratory failureHeart failure-associated hyperventilationHypoventilation syndromes
05

Safety considerations

Risk of seizures (especially with doxapram)Cardiovascular side effects including tachycardia and hypertensionGastrointestinal distressMetabolic acidosis or electrolyte imbalancesPotential for worsening ventilation-perfusion (V/Q) mismatch
06

Interacting drugs

Doxapram

8 more in the full profile.

07

Biomarkers

Arterial partial pressure of carbon dioxide (PaCO2)Arterial partial pressure of oxygen (PaO2)Arterial blood pHMinute ventilation (VE)Tidal volume (VT)Respiratory rate (RR)

Beyond the preview

Go deeper on Ventilation regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventilation regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call